News

September 23, 2025

If you are in Krakow this week, don’t miss this chance to hear our CEO, prof. Jacek Jemielity talk about the “New developments in mRNA technology” at the RNA Biology and Medicine mini-symposium organised by Małopolska Centre of Biotechnology...

September 22, 2025

We are proud to announce that this year our Founder and CEO, prof. Jacek Jemielity will receive “Stanislaw Kostanecki Medal” award for his extraordinary achievements in the field of organic chemistry from Polish Chemical Society. Jacek will receive the...

September 16, 2025

On 18-19 September in Munich, during a R&D Symposium organised by WACKER, our Senior mRNA Specialist, Marcelina Bednarczyk, PhD, will present a poster “AvantCap® Q line – novel tetranucleotide cap analogs with superior in vitro and in vivo potential”....

September 15, 2025

This week in Coronado, California, our team will participate in the 2nd Annual Meeting of Alliance for mRNA Medicines – ASCENT. Our Co-founder and Director of Research and Quality Development, Marek Baranowski will present our company, and our Director...

July 4, 2025

Unlock the full potential of your mRNA with ExploRNA’s Cap Analogs 5’ cap structure is a crucial element of every eukaryotic mRNA molecule. Beyond its well-known role in protecting mRNA against premature degradation and initiation of translation, it is...

June 4, 2025

On the 24th of June in NYC our CEO Jacek Jemielity will present at “mRNA Horizons: Investor Summit for Breakthroughs in Medicine”, an event organised by Alliance for mRNA Medicines and astr partners. Join Jacek, Tomasz Piec, Piotr Stępniak...

June 4, 2025

We are looking forward to the next week at Biotechnology Innovation Organization International Convention in Boston! If you haven’t already, plan to stop by The Poland Pavilion (# 672) or schedule a meeting with our Member of the Board...

April 22, 2025

We are proud to announce that ExploRNA Therapeutics has gained ISO 9001:2015 Certification from LL-C (Certification) for its quality management system, applicable to the production and sale of nucleotides, nucleic acids, and their derivatives. ISO 9001 is a globally...

March 3, 2025

We are moments away from the RNA Leaders Europe Congress in Basel. It is a perfect opportunity to talk to Tomasz Piec and Piotr Stępniak about our new cap analogs. Find out more and get inspired to create better...

February 28, 2025

Our CEO, prof. Jacek Jemielity was invited to give a seminar at the RNA Therapeutics Institute at UMass Chan Medical School. We are very proud for our leader to be recognised by the top RNA scientists in the world....